| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5645313 | Annals of Allergy, Asthma & Immunology | 2017 | 6 Pages |
Abstract
LAIV use in asthma was mostly in persons with intermittent or mild persistent asthma. LAIV was not associated with an increased risk of medically attended respiratory adverse events.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Jonathan MD, MPH, Melissa MPH, Theresa MD, MPH&TM, Roger MD, Edward A. MD, Lisa A. MD, MPH, Steven J. MD, PhD, Grace M. MD, MPH, Allison L. PhD, James MD, MPH, Matthew F. MD, Vaccine Safety Datalink Vaccine Safety Datalink,